Clinical Scorecard: Zinc's Role in Type 2 Diabetes and Diabetic Kidney Disease: Emphasis on Hypoxia
At a Glance
Category
Detail
Condition
Type 2 Diabetes Mellitus and Diabetic Kidney Disease
Key Mechanisms
Zinc signaling promotes expression of hypoxia-inducible factor-1α (HIF-1α) and has anti-inflammatory, antioxidant, anti-apoptotic, and anti-fibrotic effects.
Target Population
Individuals with Type 2 Diabetes Mellitus, particularly those at risk for Diabetic Kidney Disease.
Care Setting
Clinical management of diabetes and chronic kidney disease.
Key Highlights
30-40% of individuals with T2DM develop Diabetic Kidney Disease (DKD).
Zinc homeostasis is critical for tolerating hypoxic conditions.
Zinc deficiency can impair insulin synthesis and secretion.
Zinc supplementation may reduce blood glucose and improve insulin responsiveness.
Optimal zinc intake ranges from 8.9 to 12.2 mg per day.
Guideline-Based Recommendations
Diagnosis
Monitor for signs of hyperglycemia and renal function in patients with T2DM.
Management
Consider zinc supplementation in individuals with diabetes to improve metabolic parameters.
Monitoring & Follow-up
Regularly assess zinc levels and renal function in patients with T2DM.
Risks
Zinc deficiency and excess can both increase the risk of diabetes.
Patient & Prescribing Data
Patients with Type 2 Diabetes Mellitus, especially those with or at risk for DKD.
Zinc supplementation should be tailored regarding form, dosage, and duration.
Clinical Best Practices
Maintain optimal zinc levels to support metabolic health in diabetes.
Evaluate the risk of DKD in patients with T2DM regularly.
